Hospital Clinico San Cecilio
Granada 18016
0 studies enrolling now · 3 studies all time
What they study most
Early Breast Cancer, HIV Infection, Human Immunodeficiency Virus
Studies at this site
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) — Completed
- Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
- Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir — Completed